◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

AGIOS PHARMACEUTICALS, INC.

CIK: 1439222 SIC: 2834
$54.03M
Revenue
$-412.78M
Net Income
88.26%
Gross Margin
-873.87%
Op. Margin
$-679.80M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 13 of 13 annual reports available (2013 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
FY 2015
(Dec 31, 2015)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
+ Total Revenue $54.03M $54.03M $36.50M $26.82M $14.24M - $203.20M $117.91M $94.39M $43.01M $69.89M $59.12M $65.36M $25.55M
Revenue Growth % 0.0% 48.0% 36.1% 88.4% nan% -100.0% 72.3% 24.9% 119.4% -38.5% 18.2% -9.5% 155.8% nan%
Cost of Revenue $6.34M $6.34M $4.17M $2.88M $1.70M - $2.81M $1.32M $1.40M - - - - -
+ Gross Profit $47.68M $47.68M $32.33M $23.94M $12.54M - $200.39M $116.59M $92.99M $43.01M $69.89M - - -
Gross Margin % 88.3% 88.3% 88.6% 89.3% 88.0% nan% 98.6% 98.9% 98.5% 100.0% 100.0% nan% nan% nan%
Operating Expenses $526.16M $526.16M $462.24M $418.31M $403.29M $378.42M $519.35M $544.25M $456.87M $363.81M $270.88M $177.82M $119.49M $64.43M
Research & Development $339.54M $339.54M $301.29M $295.53M $279.91M $256.97M $367.47M $410.89M $341.32M $292.68M $220.16M $141.83M $100.37M $54.50M
Selling General & Admin $180.28M $180.28M $156.78M $119.90M $121.67M $121.44M $149.07M $132.03M $114.14M $71.12M $50.71M - - -
+ Operating Income $-472.13M $-472.13M $-425.74M $-391.49M $-389.05M $-378.42M $-316.15M $-426.33M $-362.48M $-320.79M $-200.99M $-118.70M $-54.13M $-38.88M
Operating Margin % -873.9% -873.9% -1166.5% -1459.5% -2732.1% nan% -155.6% -361.6% -384.0% -745.8% -287.6% -200.8% -82.8% -152.2%
Interest Income - - - - $12.79M $836.00K $6.61M $14.86M $16.45M $6.12M $2.51M $968.00K $203.00K $55.00K
Other Income/Expense $1.96M $1.96M $6.49M $6.05M $6.75M $14.43M - - - - - - - -
Income Before Tax - $-413.80M $717.97M $-352.09M $-231.80M $-356.51M $-329.31M $-301.41M - - $-198.47M $-117.73M $-53.93M $-38.83M
Income Tax Expense - $-1.02M $44.24M - - - - - - - - - $-426.00K $579.00K
+ Net Income $-412.78M $-412.78M $673.73M $-352.09M $-231.80M $1.60B $-327.37M $-411.47M $-346.03M $-314.67M $-198.47M $-117.73M $-53.50M $-39.41M
Net Margin % -764.0% -764.0% 1845.9% -1312.6% -1627.8% nan% -161.1% -349.0% -366.6% -731.6% -284.0% -199.1% -81.9% -154.2%
Basic EPS -7.11 -7.12 11.86 -6.33 -4.23 26.55 -4.74 -6.86 nan nan nan nan nan nan
Diluted EPS -7.11 -7.12 11.64 -6.33 -4.23 26.55 -4.74 -6.86 nan nan nan nan nan nan
Basic Shares Outstanding - 58.0M 56.8M 55.7M 54.8M 60.4M 69.0M 60.0M - - - - - -
Diluted Shares Outstanding - 58.0M 57.9M 55.7M 54.8M 60.4M 69.0M 60.0M - - - - - -
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
FY 2015
(Dec 31, 2015)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
Cash & Cash Equivalents $89.13M $76.25M $88.20M $139.26M $203.13M $127.44M $80.93M $70.50M $102.72M $160.75M $71.76M $14.03M $71.56M
Inventory $32.92M $27.62M $19.08M $8.49M - $14.70M $7.33M $869.00K - - - - -
Other Current Assets $44.13M $40.16M $35.02M $38.95M $39.84M $23.65M $24.18M $17.17M $17.49M $10.26M $8.73M $4.81M $2.50M
Total Current Assets $942.05M $965.60M $833.84M $832.77M $1.06B $636.68M $611.70M $613.78M $445.26M $559.89M $337.33M $359.55M $169.75M
Property Plant & Equipment $10.78M $11.68M $15.38M $22.99M $28.92M $32.29M $31.47M $24.32M $24.43M $25.34M $23.22M $6.39M $3.76M
Other Non-current Assets $3.93M $4.72M $4.06M $3.96M $2.90M $1.12M - $238.00K $891.00K $1.61M $611.00K $590.00K $4.00K
Total Assets $1.30B $1.66B $937.12M $1.24B $1.44B $852.95M $890.74M $858.46M $614.40M $619.09M $420.06M $491.90M $201.21M
Accounts Payable $18.36M $16.64M $9.78M $18.62M $16.70M $26.84M $21.90M $17.88M $22.77M $17.11M $14.75M $11.07M $3.68M
Accrued Liabilities $45.46M $46.86M $43.17M $30.35M $31.97M $60.14M $53.14M $42.15M $34.03M $32.00M $16.00M $14.02M $6.59M
Deferred Revenue - - - - - - $10.93M $32.71M $37.84M $35.91M $19.66M $35.69M $25.07M
Other Current Liabilities - - - - - - - - - - - $6.00K $9.00K
Total Current Liabilities $82.21M $81.16M $67.95M $62.63M $59.83M $94.39M $92.89M $93.50M $94.94M $88.43M $52.89M $61.09M $36.93M
Other Non-current Liabilities $90.00K $880.00K $1.16M $3.28M - - - - - - - - $6.00K
Total Liabilities $104.11M $122.24M $126.10M $137.90M $145.76M $453.45M $250.21M $170.92M $238.89M $260.50M - - -
Common Stock - - - - $71.00K $69.00K $68.00K $58.00K $49.00K $42.00K $38.00K $37.00K $31.00K
Retained Earnings $-561.71M $-148.92M $-822.65M $-470.56M $-238.76M $-1.84B $-1.52B $-1.10B $-798.06M $-483.15M $-284.68M $-166.95M $-113.44M
Treasury Stock $802.49M $802.49M $802.49M $802.49M $802.49M - - - - - - - -
Total Stockholders Equity $1.19B $1.54B $811.02M $1.10B $1.29B $399.50M $640.53M $687.54M $375.50M $358.59M $345.12M $424.37M $131.48M
Total Liabilities & Equity $1.30B $1.66B $937.12M $1.24B $1.44B $852.95M $890.74M $858.46M $614.40M $619.09M $420.06M $491.90M $201.21M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
FY 2015
(Dec 31, 2015)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
Net Income $-502.07M $-412.78M $673.73M $-352.09M $-231.80M $1.60B $-327.37M $-411.47M $-346.03M $-314.67M $-198.47M $-117.73M $-53.50M $-39.41M
Depreciation & Amortization - - - - - - - $8.09M $7.17M $6.43M - - - -
Stock-based Compensation $89.96M $52.55M $42.85M $44.77M $49.30M $53.51M $75.12M $72.37M $73.36M $47.81M $42.09M $31.96M $11.51M $3.03M
Change in Receivables $6.58M $6.47M $1.30M $604.00K $2.21M - - - - - - - - -
Change in Inventory $10.53M $5.30M $8.54M $10.58M $8.49M - $7.37M $6.46M $869.00K - - - - -
Change in Payables $9.00K $1.75M $6.60M $-8.73M $3.44M $1.86M $5.89M $3.72M $-5.49M $5.33M $3.50M $4.21M $7.58M $30.00K
Operating Cash Flow $-673.08M $-372.98M $-389.84M $-296.06M $-309.48M $-407.32M $-290.76M $-370.62M $-304.42M $-285.23M $38.56M $-76.95M - $-56.40M
Capital Expenditure $6.72M $4.32M $1.69M $999.00K $4.88M $5.74M $14.91M $12.17M $6.99M $4.63M $9.91M $20.16M $2.22M $1.29M
Investing Cash Flow $681.32M $377.18M $363.44M $239.57M $243.26M $1.25B $75.75M $91.44M $-273.82M $-57.91M $-119.35M $128.31M - $-87.22M
Stock Issued - - - - - - - $277.20M $516.21M $270.25M $162.15M - $333.58M $113.37M
Stock Repurchased - - - - - $802.49M - - - - - - - -
Financing Cash Flow $11.98M $8.68M $14.44M $5.43M $2.35M $-765.77M $261.52M $289.61M $546.02M $285.11M $169.78M $6.37M - $123.88M
Net Change in Cash $20.22M $12.88M $-11.96M $-51.05M $-63.87M $75.69M $46.51M $10.43M $-32.22M $-58.03M $88.99M $57.73M $-57.53M $-19.74M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $12.88M - $34.06M -
Cost of Revenue $1.68M - $4.47M -
Operating Expenses $129.75M - $384.62M -
Research & Development $86.80M - $251.48M -
Selling General & Admin $41.27M - $128.67M -
Operating Income $-116.87M - $-350.55M -
Other Income/Expense $67.00K - $1.84M -
Income Before Tax $-103.43M - $-304.74M -
Income Tax Expense - - - -
Net Income $-103.43M $-96.12M $-304.74M -
Basic EPS -1.78 - -5.27 -
Diluted EPS -1.78 - -5.27 -
Basic Shares Outstanding $58.14M - $57.85M -
Diluted Shares Outstanding $58.14M - $57.85M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $92.71M $76.25M
Inventory $32.03M $27.62M
Other Current Assets $43.19M $40.16M
Total Current Assets $1.03B $965.60M
Property Plant & Equipment $10.68M $11.68M
Other Non-current Assets $3.93M $4.72M
Total Assets $1.39B $1.66B
Accounts Payable $19.55M $16.64M
Accrued Liabilities $37.22M $46.86M
Total Current Liabilities $74.76M $81.16M
Other Non-current Liabilities $90.00K $880.00K
Total Liabilities $101.38M $122.24M
Retained Earnings $-453.67M $-148.92M
Treasury Stock $802.49M $802.49M
Total Stockholders Equity $1.28B $1.54B
Total Liabilities & Equity $1.39B $1.66B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-103.43M $-96.12M $-304.74M -
Stock-based Compensation - - $38.43M -
Change in Receivables - - $920.00K -
Change in Inventory - - $4.42M -
Change in Payables - - $2.89M -
Operating Cash Flow - - $-276.76M -
Capital Expenditure - - $3.20M -
Investing Cash Flow - - $287.11M -
Financing Cash Flow - - $6.12M -
Net Change in Cash - - $16.46M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...